Clinical Trial

Prospective Evaluation of Asians With CRT for Heart Failure

Study acronym: PEACH
Recruiting
View on ClinicalTrials.gov →
Summary
Aim:To determine the baseline characteristics of heart failure patients in Singapore undergoing cardiac resynchronization therapy (CRT); the long term outcome and predictors of response to CRT. Methodology:Among patients undergoing CRT for severe heart failure according to indications stipulated in international Cardiology guidelines, baseline demographic data is collected. Age, gender, NYHA functional class, co-morbidities, QRS width on ECG, presence of left bundle branch block pattern on ECG, presence of atrial fibrillation, left ventricular ejection fraction (LVEF) on echocardiogram, ventricular dimensions, 6 min walk test distance are collected. In addition, during the CRT implant procedure, blood is drawn from the vascular access and analysed for NT-pro BNP levels and other biomarkers of heart failure. The echocardiographic and ECG parameters and blood biomarkers are reanalysed at 6 months and 12 months following CRT implant. Response to CRT is defined as a reduction in the iLVESV (left ventricular end-systolic volume index to body surface area) of \>/= 15% and/or an increase in the LVEF of \>/= 10%.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2016-06-27; most recent amendment 2021-03-07.
Trial Details
NCT Number NCT02814942
Lead Sponsor National University Heart Centre, Singapore
Conditions Heart Failure, Cardiac Resynchronisation Therapy
Enrollment 500 participants
Start Date 2011-01
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2021-03-09